Metraipolis › archive › dc_19d5db2fc082
Case Report: Multimodal immunotherapeutic regimen (envafolimab + chemotherapy + radiotherapy) for four synchronous primary malignant neoplasms: a case report… — Europe PMC PMID:41584613
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41584613
- DOI
- 10.3389/fonc.2025.1727323
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T23:31:01.533Z
- SHA-256 of the archived text
7c662c4e724082a3c0859d8aad650eb5ccce6eba08bbaf2172cf72d242b04b53- Stable URL of this page
https://metraipolis.com/documento/dc_19d5db2fc082
How to cite
Case Report: Multimodal immunotherapeutic regimen (envafolimab + chemotherapy + radiotherapy) for four synchronous primary malignant neoplasms: a case report… — Europe PMC PMID:41584613 — Europe PMC (en), https://europepmc.org/article/MED/41584613 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_19d5db2fc082 (Metraipolis archive dc_19d5db2fc082, sha256 7c662c4e724082a3c0859d8aad650eb5ccce6eba08bbaf2172cf72d242b04b53)
BibTeX
@misc{dc19d5db2fc082,
title = {Case Report: Multimodal immunotherapeutic regimen (envafolimab + chemotherapy + radiotherapy) for four synchronous primary malignant neoplasms: a case report… — Europe PMC PMID:41584613},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41584613},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_19d5db2fc082; sha256 7c662c4e724082a3c0859d8aad650eb5ccce6eba08bbaf2172cf72d242b04b53},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41584613. Agents can read the archived copy with the MCP tool read_document.